Ardan Equity

Formularies from P&T to point of care: MMIT brings transparency and guidance to pharmacy and medical benefit information. Payers, pharmaceutical companies, providers and pharmacies use our data and workflow app to provide clarity from P&T to the point of care, ensuring consistent managed care decisions across the healthcare market.

Mediware is a specialist provider of information systems focused on complex areas of healthcare. Through their more than 25 years of experience, their focus has evolved from departmental systems residing in pharmacies and blood banks – to broader healthcare solutions that encapsulate clinical workflows to deliver a start-to-finish ClosedLoop™ environment for information and process support.

HealthEdge provides modern, disruptive technology that delivers for the first time, a suite of products that enables healthcare payors to leverage new business models, improve outcomes, drastically reduce administrative costs, and connect everyone in the healthcare delivery cycle. Their next-generation enterprise product suite, HealthRules, is built on modern, patented technology and is delivered to customers via the HealthEdge Cloud or on-site deployment. They enable their customers to radically innovate, drastically reduce costs, and efficiently address the business imperatives of the evolving healthcare economy. HealthEdge was founded by Albert Waxman of Psilos Group and Rob Gillette in December 2004. In January 2005, the company acquired over $125 million in intellectual property and other assets. This technology served as the foundation for the patented, award-winning HealthRules product suite. In December 2012, HealthEdge acquired Click4Care, a care management, and utilization management software company, adding next-generation clinical capabilities to the award-winning HealthRules product suite. HealthEdge is headquartered in Burlington, Massachusetts, and maintains an R&D center in Powell, Ohio.

Intelerad provides medical imaging business solutions and services for radiology groups, hospitals, imaging centers, and teleradiology businesses.

Corrona delivers real-world evidence through syndicated registry data and analytics services to help biopharmaceutical companies demonstrate the value and differentiation of their products to clinicians, patients, payers, and regulators. Corrona operates six autoimmune registries across the USA, Canada, and Japan, collecting data from over 400 participating investigator sites. Corrona's data are unmatched in depth and completeness within clinical measures and patient reported outcomes. Corrona also conducts active safety surveillance to support regulatory commitments for 14 new drug approvals, including formal post authorization safety studies. The company's mission is to advance patient care and improve treatment with real-world data analysis. Corrona was founded on 2000 an d is headquartered in Waltham, Massachusetts.